Corient Private Wealth’s Comera Life Sciences Holdings, Inc. Common Stock CMRA Stock Holding History

Corient Private Wealth’s Portfolio CMRA Stock Details CMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-493,692	Closed	-$123K	–	2377
2023 Q3	$123K	Buy	+493,692	New	+$260K	﹤0.01%	1995

Corient Private Wealth's CMRA Position: Q4 2023 in Review

Corient Private Wealth sold out of Comera Life Sciences Holdings, Inc. Common Stock (CMRA) in Q4 2023, closing a stake of 493,692 shares — an estimated $123K sold.

Corient Private Wealth first reported a position in CMRA in Q3 2023 and held it in 1 quarter. The position peaked at $123K in Q3 2023. 0 funds tracked by Wall St. Rank hold CMRA as of Q4 2023.

Corient Private Wealth reported no remaining Comera Life Sciences Holdings, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Corient Private Wealth sold 493,692 Comera Life Sciences Holdings, Inc. Common Stock shares in Q4 2023, an estimated $123K.
Corient Private Wealth first reported a position in Comera Life Sciences Holdings, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
Corient Private Wealth's Comera Life Sciences Holdings, Inc. Common Stock position peaked at $123K in Q3 2023.
0 funds tracked by Wall St. Rank held Comera Life Sciences Holdings, Inc. Common Stock as of Q4 2023.

Based on Corient Private Wealth's 13F filing for Q4 2023, filed 9 Feb 2024.